Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ross Moat currently holds 9,415 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ross Moat has been a net seller of KNSA stock. They have purchased $0 and sold $1.9M worth of shares.
Ross Moat's most recent insider trade was on Sep 4, 2025, when they sold 3,523 shares at $35.31 per share.
Ross Moat serves as Executive at Kiniksa Pharmaceuticals, Ltd. (KNSA). They have executed 55 insider transactions totaling $1.9M over their tenure at the company.
Ross Moat holds the position of Executive at Kiniksa Pharmaceuticals, Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Ross Moat has shown a selling trading pattern, with $0 in total purchases and $1.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ross Moat was on Sep 3, 2024, when they sold $1.8M worth of KNSA shares. This transaction involved 67,346 shares at $26.10 per share.
Ross Moat currently owns 9,415 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ross Moat's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ross Moat has 55 Form 4 filings on record as an insider at Kiniksa Pharmaceuticals, Ltd..
Set alerts for Ross Moat and 40,000+ other insiders.